MacMahon S, Peto R, Collins R, et al. Blood pressure, stroke, and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335: 765–774.
Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabet Care. 1994;17:1247–1251.
McFarlane SI, Jacober SJ, Winer N, et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabet Care. 2002;25:718–723.
Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E. Hypertension and diabetes mellitus: coprediction and time trajectories. Hypertension. 2018;71:422–428.
Group CD. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287:2542–2551.
Dorobanåu M, Onciul S, Darabont R, et al. Arterial hypertension epidemiology: Romania among the Balkan Countries – Data from SEPHAR Surveys. Medicina. 2014;21:10–16.
Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Inter Med. 1993;153:154–183.
Petrela E, Burazeri G, Pupuleku F, Zaimi E, Rahman M. Prevalence and correlates of hypertension in a transitional southeastern European population: results from the Albanian Demographic and Health Survey. Arch Indust Hyg and Tox. 2013;64:479–487.
Burazeri G, Goda A, Sulo G, Stefa J, Roshi E, Kark JD. Conventional risk factors and acute coronary syndrome during a period of socioeconomic transition: population-based case-control study in Tirana, Albania. Croat Med J. 2007;48: 225–233.
Boledovičová M, Hendl J, Lišková L, et al. Blood pressure relation to body composition and age: analysis of a nurse-led investigation and consultation program. Med Sci Monit. 2013;19:612.
Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Pub Health. 1994;84: 1768–1774.
Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38:809–814.
Hicks LS, Fairchild DG, Horng MS, Orav EJ, Bates DW, Ayanian JZ. Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity. Hypertension. 2004;44:429–434.
Majernick TG, Zacker C, Madden NA, Belletti DA, Arcona S. Correlates of hypertension control in a primary care setting. Am J Hypertens. 2004;17:915–920.
Andriciuc C. Country report for Albania. International Diabetes Federation; 2018. http://www.idf.org/web-data/docs/idfeurope/Country%20report%20for%20ALBANIA%20pub.pdf. Accessed May 12, 2020.
Doupis J, Tentolouris N, Mastrokostopoulos A, et al. Prevalence of type 2 diabetes in the southwest Albanian adult population; 2017. http://www.rrh.org.au. Accessed May 12, 2020.
Toti F, Golay A, Bejtja G. Increased prevalence of obesity and type 2 diabetes in Albanian population. Geneva Health Forum: a critical shift to chronic conditions: learning from the frontliner; 2013: 18–20. http://www.ghf12.org/?p=3038. Accessed May 12, 2020.
Menotti A, Mulder I, Nissinen A, Giampaoli S, Feskens EJ, Kromhout D. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: the FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol. 2001;54: 680–686.
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.
Kuneš J, Zicha J. Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clin Sci (Lond). 2006;111:295–305.